STOCK TITAN

Nuwellis (NASDAQ: NUWE) releases Q2 2025 and first-half financial results

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Nuwellis, Inc. reported that it has released its financial results for the three and six months ended June 30, 2025. The company furnished this update through a press release dated August 14, 2025, which is attached as Exhibit 99.1. The information was provided under a current report and is treated as furnished rather than filed under securities law, which affects how it is subject to certain legal liabilities.

Positive

  • None.

Negative

  • None.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2025

Nuwellis, Inc.
(Exact Name of Registrant as Specified in its Charter)

Delaware
001-35312
No. 68-0533453
(State or Other Jurisdiction of Incorporation or Organization)
(Commission File Number)
(I.R.S. Employer Identification No.)

12988 Valley View Road, Eden Prairie, MN 55344
(Address of Principal Executive Offices) (Zip Code)

(952) 345-4200
(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
NUWE
Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02
Results of Operations and Financial Condition.

On August 14, 2025, Nuwellis, Inc. (the “Company”) issued a press release reporting its financial results for the three and six months ended June 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information included in this Current Report on Form 8-K (including Exhibit 99.1) is furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits

Exhibit No. Description

99.1
Press Release, dated August 14, 2025, reporting the financial results of Nuwellis, Inc. for the three and six months ended June 30, 2025.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 14, 2025
NUWELLIS, INC.
   
 
By:
/s/ John L. Erb
 
 
Name:
John L. Erb
 
 
Title:
President and Chief
Executive Officer
 



FAQ

What did Nuwellis, Inc. (NUWE) disclose in this 8-K filing?

Nuwellis, Inc. disclosed that it issued a press release reporting its financial results for the three and six months ended June 30, 2025, and furnished that release as Exhibit 99.1.

Which period do Nuwellis, Inc.’s latest reported results cover?

The reported financial results cover the three and six months ended June 30, 2025.

How were Nuwellis, Inc.’s Q2 2025 results provided to investors?

The results were provided in a press release issued on August 14, 2025, which is attached to the report as Exhibit 99.1 and incorporated by reference.

Are the Nuwellis, Inc. Q2 2025 results considered filed with the SEC?

No. The company states that the information, including Exhibit 99.1, is furnished under Item 2.02 and is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.

Who signed the Nuwellis, Inc. current report on the financial results release?

The report was signed on behalf of Nuwellis, Inc. by John L. Erb, the company’s President and Chief Executive Officer.

What exchange is Nuwellis, Inc. common stock listed on and under what symbol?

Nuwellis, Inc. common stock is listed on the Nasdaq Capital Market under the trading symbol NUWE.
Nuwellis Inc

NASDAQ:NUWE

NUWE Rankings

NUWE Latest News

NUWE Latest SEC Filings

NUWE Stock Data

1.34M
1.87M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
EDEN PRAIRIE